Table 2:
Affinity-Based Interaction | Peptide Gel Matrix | Cargo delivered | Release Duration | Ref | Notes |
---|---|---|---|---|---|
Electrostatic: Specific | α–helical peptide amphiphile + Heparin = β sheet nanofiber | Growth factors: FGF-2-rhodamine | 10 days | 46 | |
Peptide-PEG conjugated gels + Heparin | Heparin binding proteins | ~ 10 days | 48 | ||
Electrostatic: Non-specific | Heparin-mimetic peptide amphiphile | Growth factors: VEGF | 7 days | 49 | |
β hairpin: HLT2 (cationic) | Proteins: α-lactalbumin, lactoferrin, myoglobin | 28 days | 58 | ||
β hairpin: VEQ3 (anionic) | Proteins: α-lactalbumin, lactoferrin, myoglobin | 28 days | 58 | ||
β sheet: RADA16 | Growth factors: β-FGF, VEGF, BDNF | > 2 days | 63 | ||
β hairpin: STINGel MDP - K2(SL)6K2 | Cyclic dinucleotide (CDN) | > 24 hours | 64 | ||
β hairpin: SLac MDP- (KSLSLSLRGSLSLSLKGRGDS) | Small molecule drugs: suramin | > 30 days | 66 | ||
β hairpin: AcVES3 | Proteins: EGFP; Cytokines: IFNα | 10 days | 60 | Cargo modified with affinity tags | |
Hydrophobic | β hairpin: MDP - K2(SL)3(SA)(SL)2K2 | Small molecule drugs: SN-38, Diflunisal, Etodolac | > 8 days | 67,68 | |
Single amino acid hydrogel nanoparticles (HNPs) | Small molecule drugs: 5-fluorouracil | t1/2 = 3–9 hrs | 60 | ||
MITCH gel | QK (VEGF-mimetic peptide) | > 21 days | 70 | Cargo modified with affinity tags | |
Combination Systems: Electrostatic & Hydrophobic | Phe-modified RADA | Small molecule drugs: 5-fluorouracil | n/a | 72 | |
Hexapeptide: NH2-WLVFFK-COOH | Small molecule drugs: 5-fluorouracil, ciprofloxacin | 72 hrs | 73 | ||
Composite RADA gel-chitosan system with β-Cyclodextrin carriers | Small molecule drugs: dexamethasone | ~ 9 days (pH 7) > 9 days (pH 6) |
74 | ||
Reversible Covalent: Schiff Base | Peptides with aldehyde functionality: Nap-GDFDFDpY-CHO | Small molecule drugs: Doxorubicin, Gemcitabine | > 12 hours | 80,81 | |
Reversible Covalent: Hydrazone | Peptide amphiphile modified with hydrazine | Small molecule drugs: nabumetone | > 24 days | 82 |